TENAX THERAPEUTICS, INC. — Director's Dealing 2011

Dec 20, 2011

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: OXYGEN BIOTHERAPEUTICS, INC. (oxbt)
CIK: 0000034956
Period of Report: 2011-12-15

Reporting Person: Jebsen Michael B (Chief Financial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2011-12-15	Common stock	D	279	$1.91	Acquired	6435	Direct